CXCL11 and colon adenocarcinoma: Cao et al. [29] observed similar results; they found that CXCL11 was highly differentially expressed in colon adenocarcinoma (COAD), but played a significant defensive role in the development of COAD and contributed to a more favorable prognosis for patients diagnosed with COAD.